FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1169 October 15, 1998 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Eric J. Topol, with eight others. 2732 pp., illustrated. Philadelphia, Lippincott–Raven, 1998. $125. ISBN 0-397-51592-8.
Edited by Eric J. Topol, with eight others. 3153 pp., illustrated. Philadelphia, Lippincott–Raven, 1998. $275. ISBN 0-7817-1596-2.

The end of the 20th century marks a pivotal point in the history of cardiovascular medicine. There has been an explosive growth in the knowledge base relevant to the field, with new developments ranging from technology-driven interventional strategies and device therapy to insights into the molecular biology and genetics of cardiovascular disease. At the same time, physicians find themselves in an environment of limited financial resources, managed care, and evidence-based medicine. In an era of rapidly emerging diagnostic and therapeutic choices, the individual physician faces cost considerations and the scrutiny of evidence-based decision making, a trend seen throughout the world.

. . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.